Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC376

Ripretinib, eða lyfjafræðileg tækt salt þess

  • Status:
    Veitt
  • Application date:
    11.5.2022
  • Application published:
    15.6.2022
  • Grant published:
    15.8.2025
  • Max expiry date:
    23.11.2036
  • Medicine name:
    QINLOCK
  • Medicine for children:
    No

Timeline

Today
11.5.2022Application
15.6.2022Publication
15.8.2025Registration
23.11.2036Expires

Marketing license

  • IS authorization number:
    EU/1/21/1569/001-002
  • Date:
    14.12.2021
  • Foreign authorization number:
    EU/1/21/1569
  • Date:
    18.11.2021

Owner

  • Name:
    Deciphera Pharmaceuticals, LLC
  • Address:
    643 Massachusetts, Suite 200, Lawrence, Kansas US

Agent

  • Name:
    Kjartan Ragnars, hrl.
  • Address:
    Hrauntungu 66, 200 Kópavogi

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 09.07.2025

Upload documents